Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Patrocinado

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Postado

95

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

Trade Tower Limited IPO allotment finalized

KATHMANDU: The IPO allotment of Trade Tower Limited was completed in Kathmandu today. From Jestha...

Por 0 2

Landing gear snag: Air India Delhi-Vadodara flight makes emergency landing

Por 0 3

'It's okay': Yuvraj takes a cheeky dig at Australia as SA win WTC title

Yuvraj Singh celebrated South Africa's historic World Test Championship victory over Australia at...

Por 0 8

Uttarakhand chopper crash: In Cyprus, PM Modi speaks to CM Pushkar Dhami; assures cooperation from Centre

Por 0 12

Drama! Johnson slams Hazlewood for playing in IPL over national duty: 'We've ...'

Mitchell Johnson has criticised Josh Hazlewood's choice to play in the IPL instead of preparing...

Por 0 16